SCHEMBL7010260

SCHEMBL7010260

COc1c(F)c(C(=O)O)cc(F)c1Br

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.49
LCK P06239 1/20 0.43
FYN P06241 1/20 0.43
GPR35 Q9HC97 1/20 0.41
TPMT P51580 2/20 0.40
ALDH1A1 P00352 2/20 0.38
HPGD P15428 2/20 0.38
LMNA P02545 1/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
RAB9A P51151 1/20 0.38
KDM4E B2RXH2 1/20 0.38
MAPT P10636 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
PTPN1 P18031 2/20 0.37
PKM P14618 1/20 0.36
KEAP1 Q14145 1/20 0.36
NFE2L2 Q16236 1/20 0.36
CRBN Q96SW2 1/20 0.36
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27486423 0.86 HSD17B10 (0.49) HSD17B10LCKFYNGPR35TPMT
SCHEMBL20425514 0.86 HSD17B10 (0.53) HSD17B10LCKFYNGPR35TPMT
SCHEMBL25256255 0.84 HSD17B10 (0.54) HSD17B10LCKFYNGPR35TPMT
SCHEMBL28424948 0.84 HSD17B10 (0.44) HSD17B10LCKFYNTPMTALDH1A1
SCHEMBL607945 0.84 HSD17B10 (0.44) HSD17B10LCKFYNTPMTALDH1A1
SCHEMBL17494276 0.83 HSD17B10 (0.46) HSD17B10LCKFYNGPR35TPMT
SCHEMBL27929289 0.83 HSD17B10 (0.49) HSD17B10LCKFYNGPR35TPMT
SCHEMBL27927680 0.82 HSD17B10 (0.43) HSD17B10LCKFYNTPMTALDH1A1
SCHEMBL31458369 0.81 HSD17B10 (0.54) HSD17B10LCKFYNGPR35TPMT
SCHEMBL6422815 0.80 HSD17B10 (0.44) HSD17B10LCKFYNTPMTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0775702-B1 NOVEL QUINOLONE- OR NAPHTHYRIDONECARBOXYLIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO LTD (JP) 2003-07-23 EP disclosed
US-20020049223-A1 Quinoline and naphthyridine carboxylic acid antibacterials ABBOTT LABORATORIES 2002-04-25 US disclosed
US-5935952-A ANTIBACTERIAL AGENT TOYAMA CHEMICAL CO., LTD. (JP) 1999-08-10 US disclosed
EP-0775702-A1 NOVEL QUINOLONE- OR NAPHTHYRIDONECARBOXYLIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 1997-05-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020049223-A1 Quinoline and naphthyridine carboxylic acid antibacterials NQO2, NQO1, NDUFA7 HSD17B10 1202/4885LCK 4739/4885FYN 4837/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.